Jennifer Ligibel, MD
Enriched profileSenior Physician, Breast Oncology Center; Professor of Medicine, Harvard Medical School · Dana-Farber Cancer Institute
Jennifer Ligibel is Senior Physician, Breast Oncology Center; Professor of Medicine, Harvard Medical School at Dana-Farber Cancer Institute. OpenAlex indexes 371 publications with 18,424 citations (h-index 60); ClinicalTrials.gov lists 17 registered studies with this person as an investigator.
Data verified 17 Oct 2026
Overview
Updated 18 Oct 2026
Jennifer Ligibel, MD, is Senior Physician, Breast Oncology Center at Dana-Farber Cancer Institute. The public record shows 371 publications with 18,424 citations (h-index 60), centered on Cancer survivorship and care, Cancer Risks and Factors, Breast Cancer Treatment Studies. It also documents an investigator role on 17 registered clinical trials, industry payments reported by 2 companies, 1 NIH-funded awards (2024–2026).
- Most recent indexed publication: 2026 · Nature communications
- Top research focus: Cancer survivorship and care
- 17 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 23 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 155.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 17 registered studies on ClinicalTrials.gov. The most recent:
- Distance-Based Exercise to Preserve Function and Prevent Disability
Sponsor: Alliance for Clinical Trials in Oncology
- Dance Study for Post-surgical Pain in Breast Cancer Survivors
Sponsor: Dana-Farber Cancer Institute
- Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
Sponsor: Dana-Farber Cancer Institute
Industry payments
Updated 18 Oct 2026
2 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20241 payment
- Gilead Sciences, Inc.Program year20211 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
70.8%Aromatase Inhibitor45.8%Letrozole100%Part D<11 patientsKinase inhibitor25%Ibrance100%Part D<11 patientsSensory organs
29.2%Corticosteroid29.2%Dexamethasone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder breast cancer patients (THRIVE)
University of Pittsburgh at Pittsburgh
FY2026$1,218,170U01CA271277 - Distance-based Exercise to preserve Function and prevENt Disability (DEFEND)
Dana-Farber Cancer Inst
FY2026$336,614U34CA293568 - Randomized Phase II Trial of Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women with Hormone Receptor Positive Advanced Breast Cancer (FastER)
University of Miami School of Medicine
FY2025$2,233,701R01CA281861
Congress activity
Updated 18 Oct 2026
64 congress contributions (2006–2026) across AACR, ASCO, ASTRO, ESMO, SABCS per OpenAlex. The most recent:
- Effect of a weight loss intervention (WLI) on quality of life (QOL) and symptoms in women with breast cancer: Results from the Breast Cancer Weight Loss (BWEL) trial.
ASCO Annual Meeting
ASCO2026Presenting author - Employment status and occupational patterns among working-age US cancer survivors, 2020-2024.
ASCO Annual Meeting
ASCO2026Co-author - Leisure-time physical activity among US cancer survivors, 2020-2024.
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial.
Nature communications
Clinical Trial2026 - Barriers to the Adoption of Healthy Lifestyle Behaviors in Patients With Cancer: Results of a National Survey.
JCO oncology practice
Article2026 - Effect of a lifestyle intervention during chemotherapy for breast cancer on quality of life.
JNCI cancer spectrum
Clinical Trial2026 - If Exercise Were a Pill, We'd All Prescribe It to Patients With Cancer. But It's Not.
Journal of clinical oncology
Article2026 - The multidisciplinary community of exercise oncology practice: current status and future directions.
Journal of the National Cancer Institute. Monographs
Review2025
Most-cited works
by citation count (OpenAlex)- 01
- 02Cancer-Related Fatigue, Version 2.2015Article949 citations2015
- 03Exercise is medicine in oncology: Engaging clinicians to help patients move through cancerArticle784 citations2019
- 04Exercise, Diet, and Weight Management During Cancer Treatment: ASCO GuidelineArticle689 citations2022
- 05
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/jennifer-ligibel-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
boulder.vumedi.com/channel/dana-farber-cancer-institute/tab/ascor-2023/video/ascor-2023-insights-effect-of-a-telephone-based-weight-loss-intervention-on-weight-at-12-months-in-w
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →boulder.vumedi.com ↗ - Other
broadcastmed.com/cancer/1411/videos/asco-2023-breast-cancer-research-presented-by-jennifer-ligibel-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →broadcastmed.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
- MD
Washington University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
Editorial & leadership roles
journal and society appointments- Director
Leonard P. Zakim Center for Integrative Therapies and Healthy Living
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗ - Director
Center for Faculty Well-Being
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
Secondary affiliations
appointments beyond the home institution- Komen Scholar
Susan G. Komen Foundation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →spreaker.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →realpink.komen.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Kenneth Anderson, MD
Dana-Farber Cancer Institute
Frank Hodi, MD
Dana-Farber Cancer Institute
Paul Richardson, MD
Dana-Farber Cancer Institute
Toni Choueiri, MD
Dana-Farber Cancer Institute
Paul Ridker, MD
Brigham and Women's Hospital
Edward Giovannucci, MD, ScD, MPH
Harvard T.H. Chan School of Public Health
Stephen Chanock, MD
National Cancer Institute (NCI)
Wei Zheng, MD, PhD, MPH
Vanderbilt University Medical Center